Eli Lilly And Company lobbies on its own behalf. For Q3 2026 it reported $2.59M across 1 client report and lists 11 lobbyists across its filings. Issues include Copyright/Patent/Trademark, Consumer Issues/Safety/Products, Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| ELI LILLY AND COMPANY | $2.59M | Copyright/Patent/Trademark, Consumer Issues/Safety/Products, Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $9.62M | 1 |
| 2025 | $10.60M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.